Quick Answer
FATE THERAPEUTICS INC reported Net Income Loss of -$136.32 million for the year ending 2025.
- FATE THERAPEUTICS INC showed an increase of +26.8% in Net Income Loss from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), FATE THERAPEUTICS INC's Net Income Loss has declined by 1,801.5%.
- Historical annual values: Fiscal year 2025: -$136.32 million | Fiscal year 2024: -$186.26 million | Fiscal year 2023: -$160.93 million | Fiscal year 2022: -$281.72 million | Fiscal year 2021: -$212.15 million | Fiscal year 2020: -$173.39 million | Fiscal year 2019: -$98.15 million | Fiscal year 2018: -$66.60 million | Fiscal year 2017: -$42.95 million | Fiscal year 2016: -$33.46 million | Fiscal year 2015: -$29.99 million | Fiscal year 2014: -$25.88 million | Fiscal year 2013: -$20.89 million | Fiscal year 2012: -$14.24 million | Fiscal year 2011: -$13.43 million | Fiscal year 2010: -$16.22 million | Fiscal year 2009: -$13.33 million | Fiscal year 2008: -$7.17 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: